This is not the most recent version of the article. View current version (20 AUG 2013)

Intervention Review

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

  1. Katrina Williams1,*,
  2. Danielle M Wheeler2,
  3. Natalie Silove3,
  4. Philip Hazell4

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 4 AUG 2010

Assessed as up-to-date: 30 MAY 2010

DOI: 10.1002/14651858.CD004677.pub2


How to Cite

Williams K, Wheeler DM, Silove N, Hazell P. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews 2010, Issue 8. Art. No.: CD004677. DOI: 10.1002/14651858.CD004677.pub2.

Author Information

  1. 1

    University of New South Wales & Sydney Children's Hospital, School of Women's and Children's Health, Sydney, NSW, Australia

  2. 2

    c/o Cochrane Developmental, Psychosocial and Learning Problems Group, Belfast, UK

  3. 3

    The Children's Hospital at Westmead, Child Development Unit, Westmead, New South Wales, Australia

  4. 4

    Sydney Medical School, Department of Psychiatry, Concord Clinical School, Sydney, New South Wales, Australia

*Katrina Williams, School of Women's and Children's Health, University of New South Wales & Sydney Children's Hospital, Sydney Children's Community Health Centre, Cnr Avoc & Barker Street, Randwick, Sydney, NSW, 2031, Australia. Katrina.Williams@SESIAHS.HEALTH.NSW.GOV.AU.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 4 AUG 2010

SEARCH

This is not the most recent version of the article. View current version (20 AUG 2013)

  1. You have free access to this content

    Current Version

    Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

    Katrina Williams, Amanda Brignell, Melinda Randall, Natalie Silove and Philip Hazell

    Article first published online: 20 AUG 2013 | DOI: 10.1002/14651858.CD004677.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

    Katrina Williams, Danielle M Wheeler, Natalie Silove and Philip Hazell

    Article first published online: 4 AUG 2010 | DOI: 10.1002/14651858.CD004677.pub2

  2. Version 1

    Selective serotonin reuptake inhibitors for the treatment of autism spectrum disorders

    Danielle M Wheeler, Philip Hazell, Natalie Silove and Katrina Williams

    Article first published online: 26 JAN 2004 | DOI: 10.1002/14651858.CD004677